Page last updated: 2024-11-06

mitomycin and Craniofacial Dysarthrosis

mitomycin has been researched along with Craniofacial Dysarthrosis in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"Crouzon syndrome is the most common form of craniosynostosis, and mutations in the fibroblast growth factor receptor 2 and 3 (FGFR2 and FGFR3) genes are implicated in its pathogenesis."1.48Glaucoma With Crouzon Syndrome. ( Al-Shahwan, S; Alshamrani, AA, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alshamrani, AA1
Al-Shahwan, S1

Other Studies

1 other study available for mitomycin and Craniofacial Dysarthrosis

ArticleYear
Glaucoma With Crouzon Syndrome.
    Journal of glaucoma, 2018, Volume: 27, Issue:6

    Topics: Alkylating Agents; Anterior Eye Segment; Biometry; Child; Combined Modality Therapy; Corneal Pachyme

2018